Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 121 AL 135

[Towards a vaccine against Alzheimer's?]

Dodel R.

Drug Res (Stuttg). 2013 Nov;63 Suppl 1:S18-20. doi: 10.1055/s-0033-1346715. Epub 2013 Nov 15.

Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease

Chen Y, Sun J, Peng S, Liao H, Zhang Y, Lehmann J.

Arch Pharm (Weinheim). 2013 Dec;346(12):865-71. doi: 10.1002/ardp.201300074. Epub 2013 Nov 6.

Effect and mechanism of acupuncture on Alzheimer's disease

Zeng BY, Salvage S, Jenner P.

Int Rev Neurobiol. 2013;111:181-95. doi: 10.1016/B978-0-12-411545-3.00009-2.

Alzheimer disease therapy--moving from amyloid-β to tau

Giacobini E, Gold G.

Nat Rev Neurol. 2013 Dec;9(12):677-86. doi: 10.1038/nrneurol.2013.223. Epub 2013 Nov 12.

Natural products for Alzheimer's disease therapy: basic and application

Xiao J, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1679-80. doi: 10.1111/jphp.12186.

Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment

Pinho BR, Ferreres F, Valentão P, Andrade PB.

J Pharm Pharmacol. 2013 Dec;65(12):1681-700. doi: 10.1111/jphp.12081. Epub 2013 May 16.

Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease

Konrath EL, Passos Cdos S, Klein LC Jr, Henriques AT.

J Pharm Pharmacol. 2013 Dec;65(12):1701-25. doi: 10.1111/jphp.12090. Epub 2013 Jun 20.

Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity

Bonesi M, Loizzo MR, Conforti F, Passalacqua NG, Saab A, Menichini F, Tundis R.

J Pharm Pharmacol. 2013 Dec;65(12):1726-35. doi: 10.1111/jphp.12172. Epub 2013 Nov 6.

Profile of gantenerumab and its potential in the treatment of Alzheimer's disease

Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R.

Drug Des Devel Ther. 2013 Nov 13;7:1359-64. doi: 10.2147/DDDT.S53401. eCollection 2013.

Dance with me

Aka S.

Can Nurse. 2013 Oct;109(8):30-1.

[Present and future of the tau dementia therapy]

Takashima A.

Rinsho Shinkeigaku. 2013;53(11):1040-2. doi: 10.5692/clinicalneurol.53.1040.

[Molecular targeting and translational research for new therapeutic strategies on Alzheimer's disease]

Takata K.

Yakugaku Zasshi. 2013;133(12):1389-99. doi: 10.1248/yakushi.13-00219.

[The Balance of Care approach for the development of custom-fit health care services for people with dementia on the margins of care between home and nursing home: experiences with its application in Germany]

Stephan A, Renom Guiteras A, Juchems S, Meyer G.

Z Evid Fortbild Qual Gesundhwes. 2013;107(9-10):597-605. doi: 10.1016/j.zefq.2013.10.018. Epub 2013 Nov 11.

Disease-modifying drugs in Alzheimer's disease

Ghezzi L, Scarpini E, Galimberti D.

Drug Des Devel Ther. 2013 Dec 6;7:1471-8. doi: 10.2147/DDDT.S41431.

Iron and aluminum in Alzheimer's disease

Di Lorenzo F, Di Lorenzo B.

Neuro Endocrinol Lett. 2013;34(6):504-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias